aa 861 has been researched along with Cardiovascular Stroke in 5 studies
2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone: structure given in first source
docebenone : A member of the class of benzoquinones that is p-benzoquinone in which the hydrogens are substituted by three methyl groups and a 12-hydroxydodeca-5,10-diyn-1-yl group.
Excerpt | Relevance | Reference |
---|---|---|
"The inhibitory effect of a phosphate diester of alpha-tocopherol and ascorbic acid (EPC-K1) was examined in myocardial infarction induced in rats, in comparison with a selective 5-lipoxygenase inhibitor, AA-861." | 7.69 | Inhibitory effects of a phosphate diester of alpha-tocopherol and ascorbic acid (EPC-K1) on myocardial infarction in rats. ( Katori, M; Kuribayashi, Y; Majima, M; Yoshida, K, 1996) |
"The inhibitory effect of a phosphate diester of alpha-tocopherol and ascorbic acid (EPC-K1) was examined in myocardial infarction induced in rats, in comparison with a selective 5-lipoxygenase inhibitor, AA-861." | 3.69 | Inhibitory effects of a phosphate diester of alpha-tocopherol and ascorbic acid (EPC-K1) on myocardial infarction in rats. ( Katori, M; Kuribayashi, Y; Majima, M; Yoshida, K, 1996) |
"We studied the effects of a thromboxane A2 synthetase inhibitor (RS-5186), a thromboxane A2 antagonist (ONO-3708), a 5-lipoxygenase inhibitor (AA-861) and a peptidoleukotriene antagonist (ONO-1078) on infarct size, polymorphonuclear leukocyte infiltration, gross myocardial hemorrhage and arrhythmias in the canine coronary occlusion (2 hour)-reperfusion model (5 hour)." | 3.67 | Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart. ( Hashimoto, H; Hieda, N; Ito, T; Ogawa, K; Okumura, K; Satake, T; Toki, Y, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuribayashi, Y | 1 |
Katori, M | 2 |
Majima, M | 1 |
Yoshida, K | 1 |
Hoshida, S | 1 |
Kuzuya, T | 1 |
Nishida, M | 1 |
Kim, Y | 1 |
Kitabatake, A | 1 |
Kamada, T | 1 |
Tada, M | 1 |
Ito, T | 2 |
Toki, Y | 2 |
Hieda, N | 2 |
Okumura, K | 1 |
Hashimoto, H | 2 |
Ogawa, K | 2 |
Satake, T | 2 |
Sasaki, K | 1 |
Ueno, A | 1 |
Kawamura, M | 1 |
Shigehiro, S | 1 |
Kikawada, R | 1 |
Torii, T | 1 |
5 other studies available for aa 861 and Cardiovascular Stroke
Article | Year |
---|---|
Inhibitory effects of a phosphate diester of alpha-tocopherol and ascorbic acid (EPC-K1) on myocardial infarction in rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Benzoquinones; Free Radical Scavengers; Lipoxygenase Inhibitor | 1996 |
Attenuation of neutrophil function by inhibitors of arachidonate metabolism reduces the extent of canine myocardial infarction.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Benzoquinones; Collateral Circulation; Dogs; Fatty Aci | 1989 |
Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart.
Topics: Animals; Arrhythmias, Cardiac; Benzoquinones; Cardiomyopathies; Chromones; Coronary Disease; Dogs; H | 1989 |
Reduction of myocardial infarct size in rats by a selective 5-lipoxygenase inhibitor (AA-861).
Topics: Animals; Benzoquinones; Leukotriene B4; Lipoxygenase Inhibitors; Male; Myocardial Infarction; Neutro | 1987 |
The effects of lipoxygenase inhibitor and peptidoleukotriene antagonist on myocardial injury in a canine coronary occlusion-reperfusion model.
Topics: Animals; Arrhythmias, Cardiac; Benzoquinones; Cell Movement; Chromones; Dogs; Hemodynamics; Hemorrha | 1988 |